Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose methotrexate plus low-dose methylprednisolone for acute graft-versus-host disease
ChiCTR-TRC-09000466Phase 4Completed
- Sponsor
- Peking University People's Hospital
- Start
- May 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Acute Graft-Versus-Host Disease (aGvHD) comparing Methotrexate + methylprednisolone with Methylprednisolone alone (2 arms). Primary endpoint: Grading of acute graft-versus-host disease. Started May 2007; status: completed.
02
Drugs
methotrexatemethylprednisolone
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on ChiCTR-TRC-09000466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000466.